英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
scoliate查看　scoliate　在百度字典中的解释百度英翻中〔查看〕
scoliate查看　scoliate　在Google字典中的解释Google英翻中〔查看〕
scoliate查看　scoliate　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Eye Injections for Retinal Diseases | EYLEA® (aflibercept) Injection
    EYLEA® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR)
  • EYLEA HD (aflibercept) Injection 8 mg Approved by FDA for Treatment of . . .
    EYLEA has since brought fundamental change to the retinal disease treatment landscape and is supported by a robust body of research that includes eight pivotal Phase 3 trials, 11 years of real-world experience, and more than 64 million EYLEA injections globally Regeneron continues to advance our anti-angiogenesis expertise with new solutions
  • FACT SHEET ABOUT EYLEA (aflibercept) INJECTION
    months (8 weeks) following 5 initial monthly (4 weeks) injections EYLEA may be dosed once per month, but additional benefit was not seen with this dosing plan IMPORTANT SAFETY INFORMATION FOR EYLEA® (aflibercept) INJECTION EYLEA® (aflibercept) Injection is a prescription medication administered by injection into the eye
  • Eylea Injection Treatment for Wet Macular Degeneration
    Regeneron Pharmaceuticals announced that the FDA has approved its Eylea injection treatment for wet age-related macular degeneration (AMD) The treatment, known in the scientific literature as VEGF Trap-Eye, was approved at a recommended dose of 2 mg every four weeks for the first twelve weeks, followed by 2 mg dose every two months (1 2)
  • Eylea Patient Tips: 7 things you should know - Drugs. com
    Eylea or Eyela HD treatment for Wet AMD may involve fewer eye injections per year compared to other Wet AMD treatments Eylea is usually injected every 4 or 8 weeks depending upon your condition, but some patients may be able to have injections every 12 weeks after 1 year of treatment
  • FDA Rejects Regeneron’s sBLA to Extend EYLEA HD Dosing Interval
    The move keeps Regeneron’s higher-dose anti-VEGF therapy on its current schedule, pending further clinical data Takeaways for eyecare professionals The FDA declined Regeneron’s bid to extend EYLEA HD intervals to 24 weeks; No new safety or efficacy issues were identified; 8 to 16 weeks after an initial series of three monthly injections;
  • Regeneron reveals positive results from multiple trials evaluating . . .
    EYLEA HD (known as Eylea 8 mg in the European Union and Japan) is being jointly developed by Regeneron and Bayer AG References: EYLEA HD® (aflibercept) Injection 8 mg Positive Phase 3 Results in Patients with Macular Edema following Retinal Vein Occlusion Presented at Angiogenesis Meeting Published February 8, 2025
  • FDA to review Regeneron’s sBLA for aflibercept injection 8mg
    The US Food and Drug Administration (FDA) has accepted Regeneron Pharmaceuticals’ supplemental biologics licence application (sBLA) for Eylea HD (aflibercept) injection 8mg for priority review The application aims to extend the therapy’s use for treating macular oedema after retinal vein occlusion (RVO) and to widen the dosing schedule to
  • Regeneron’s sBLA for Eylea HD accepted for priority review by FDA
    The US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license application (sBLA) from Regeneron for the high-dose (HD) formulation of aflibercept (EYLEA HD) 1 The sBLA seeks approval for EYLEA HD for both the treatment of macular edema following retinal vein occlusion (RVO), and for broadening the dosing schedule to include every-4-week, or
  • EYLEA® (aflibercept) Injection EYLEA® HD (aflibercept) Injection
    EYLEA® (aflibercept) Injection 2 mg is indicated for the treatment of patients with Neovascular (Wet) Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR) Regeneron Pharmaceuticals, Inc EYLEA full U S Prescribing Information Regeneron





中文字典-英文字典  2005-2009